Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
A
Achyut Healthcare Ltd
Score 58/100• Decent
Achyut Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health70/100
Valuation 40/100 · PB 4.6434
Technical Avoid
1M -5.673% 6M 64.873% 1Y 17.916%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#136
View details ➜
T
TTK Healthcare Ltd
Score 57/100• Decent
TTK Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 80/100 · PB 1.5629
Technical Avoid
1M 1.107% 6M -2.709% 1Y -23.337%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#137
View details ➜
P
Piramal Pharma Ltd
Score 57/100• Decent
Piramal Pharma Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health56/100
Valuation 40/100 · PB 3.2491
Technical Avoid
1M 5.668% 6M -5.407% 1Y -25.642%
Confidence100%
No promoter pledge
Weak ROEThin margins
#138
View details ➜
K
Kerala Ayurveda Ltd
Score 57/100• Decent
Kerala Ayurveda Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
Company’s Health22/100
Valuation 20/100 · PB 39.8623
Technical Avoid
1M -8.095% 6M 24.267% 1Y 56.177%
Confidence100%
Decent revenue growth
Weak ROEHigh debt/equity
#139
View details ➜
V
Vimta Labs Ltd
Score 56/100• Decent
Vimta Labs Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
Company’s Health90/100
Valuation 20/100 · PB 8.5284
Technical Avoid
1M 0.626% 6M 42.494% 1Y 160.935%
Confidence100%
Low leverage (D/E)No promoter pledge
#140
View details ➜
G
Gujarat Themis Biosyn Ltd
Score 56/100• Decent
Gujarat Themis Biosyn Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health83/100
Valuation 20/100 · PB 18.552
Technical Momentum
1M 21.335% 6M 69.22% 1Y 67.242%
Confidence100%
Low leverage (D/E)Healthy profit margins
Promoter pledge present
#141
View details ➜
C
Cohance Lifesciences Ltd
Score 56/100• Decent
Cohance Lifesciences Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health66/100
Valuation 20/100 · PB 15.659
Technical Avoid
1M -11.804% 6M -33.662% 1Y -42.637%
Confidence100%
Low leverage (D/E)Healthy profit margins
Promoter pledge present
#142
View details ➜
O
Onyx Biotec Ltd
Score 56/100• Decent
Onyx Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics, warranting cautious investment.
Company’s Health89/100
Valuation 80/100 · PB 1.2714
Technical Avoid
1M -6.905% 6M -29.73% 1Y -31.278%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#143
View details ➜
A
ANG Lifesciences India Ltd
Score 56/100• Decent
ANG Lifesciences India Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
Company’s Health29/100
Valuation 100/100 · PB 0.6331
Technical Avoid
1M -6.475% 6M 17.902% 1Y -33.391%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#144
View details ➜
R
Remus Pharmaceuticals Ltd
Score 54/100• Decent
Remus Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
Company’s Health91/100
Valuation 40/100 · PB 3.003
Technical Avoid
1M -8.311% 6M -27.304% 1Y -44.965%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#145
View details ➜
C
Coral Laboratories Ltd
Score 54/100• Decent
Coral Laboratories Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability.
Company’s Health87/100
Valuation 100/100 · PB 0.9045
Technical Avoid
1M 6.339% 6M -22.229% 1Y -39.158%
Confidence100%
Low leverage (D/E)No promoter pledge
#146
View details ➜
B
Biogen Pharmachem Industries Ltd
Score 54/100• Decent
Biogen Pharmachem Industries Ltd has a decent outlook with potential growth opportunities, but investors should be cautious due to execution risks and market sentiment.
Company’s Health42/100
Valuation 100/100 · PB 0.8444
Technical Avoid
1M -3.371% 6M -12.245% 1Y -33.846%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#147
View details ➜
S
Sudarshan Pharma Industries Ltd
Score 52/100• Decent
Sudarshan Pharma Industries Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
Company’s Health68/100
Valuation 40/100 · PB 4.9475
Technical Avoid
1M 1.373% 6M 1.388% 1Y -31.509%
Confidence100%
No promoter pledge
Thin margins
#148
View details ➜
I
IND Swift Laboratories Ltd
Score 52/100• Decent
The stock shows potential in a growing sector but faces several challenges that could impact future performance.
Company’s Health73/100
Valuation 100/100 · PB 0.7061
Technical Avoid
1M 7.474% 6M 42.435% 1Y -12.632%
Confidence100%
Low leverage (D/E)No promoter pledge
#149
View details ➜
V
Vasa Denticity Ltd
Score 48/100• Risky
Vasa Denticity Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health98/100
Valuation 20/100 · PB 14.6167
Technical Avoid
1M -1.049% 6M -4.39% 1Y 0.075%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#150
View details ➜
Showing 136 to 150 of 260 (18 Pages)